Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Pulmonary passage of canine adipose tissue-derived mesenchymal stem cells through intravenous transplantation in mouse model.

Kwon J., Kim MY., Lee S., Lee J., Yoon HY.

Animal Study on Hair & Scalp, Systemic / IV, published in J Vet Sci (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Vet Sci (2024)
Country
Korea (South)
Reported sample size
—
Source database
PubMed
PMID
38834506
PMCID
PMC11156597
DOI
10.4142/jvs.23300
Citations
2

Abstract (original English)

Importance The intravenous administration of adipose tissue-derived mesenchymal stem cells (AdMSCs) in veterinary medicine is an attractive treatment option. On the other hand, it can result in severe complications, including pulmonary thromboembolism (PTE). Objective The present study assessed the occurrence of PTE after the intravenous infusion of canine AdMSCs (cAdMSCs) into experimental animals. Methods Five-week-old male BALB/c hairless mice were categorized into groups labeled A to G. In the control group (A), fluorescently stained 2 × 10 6 cAdMSCs were diluted in 200 μL of suspension and injected into the tail vein as a single bolus. The remaining groups included the following: group B with 5 × 10 6 cells, group C with 3 × 10 6 cells, group D with 1 × 10 6 cells, group E with 1 × 10 6 cells injected twice with a one-day interval, group F with 2 × 10 6 cells in 100 μL of suspension, and group G with 2 × 10 6 cells in 300 μL of suspension. Results Group D achieved a 100% survival rate, while none of the subjects in groups B and C survived ( p = 0.002). Blood tests revealed a tendency for the D-dimer levels to increase as the cell dose increased ( p = 0.006). The platelet count was higher in the low cell concentration groups and lower in the high cell concentration groups ( p = 0.028). A histological examination revealed PTE in most deceased subjects (96.30%). Conclusions a

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMesenchymal Stem Cell TransplantationDogsMaleMice, Inbred BALB CMiceAdipose TissueMesenchymal Stem CellsPulmonary Embolism

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research